Mode
Text Size
Log in / Sign up
N/A N=20 Randomized Prevention

GO2 PEEP Study: Bidirectional Oxygenation Valve in Postoperative Atelectasis

Postoperative Atelectasis

Enrolled (actual)
20
Serious AEs
0.0%
Results posted
Feb 2022
Primary outcome: Primary: Partial Pressure of Oxygen (PaO2 Level) — 95.4; 83.5; 92.1; 85.4 mmHg

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Incentive spirometer (Device); GO2 Mouthpiece (Device)
Age
Pediatric, Adult, Older Adult
Sex
All
Sponsor
Emory University
Primary completion
Jan 2021

Outcome Measures

OutcomeResultp-value
PRIMARY
Partial Pressure of Oxygen (PaO2 Level)
95.4; 83.5; 92.1; 85.4; 91.0; 81.4
SECONDARY
Number of Participants With Normal Atelectasis Score
0; 2; 0; 0; 0; 0
SECONDARY
Oxygen Requirement
3.7; 3.7; 2.3; 2.4; 2.2; 2.1
SECONDARY
Carbon Dioxide Level
38.2; 39; 37.0; 37.2; 37.3; 36.9
SECONDARY
FEV1
86.4; 93.7; 35.9; 43.1
SECONDARY
Forced Vital Capacity (FVC)
85.7; 90.1; 38.0; 41.6
SECONDARY
Respiratory Rate
21.3; 20.5; 21.2; 17.9; 21.0; 19.2
SECONDARY
Body Temperature
36.8; 36.8; 38.0; 37.7; 37.5; 37.4

Summary

This study compares a novel breathing device, called the GO2 Mouthpiece, to the standard breathing tool called the incentive spirometer, thus improving respiratory dynamics of the postoperative patient.

Eligibility Criteria

Inclusion Criteria

  • Undergoing coronary artery bypass surgery (CABG) and/or valve replacement surgery
  • Able to provide written informed consent
  • Maintenance of an arterial line postoperatively

Exclusion Criteria

  • Active smoking, within three months of surgery
  • Forced expiratory volume in one second (FEV1) <75% predicted
  • Relative risk to develop pulmonary barotrauma as evident by history of pneumothorax or emphysema
  • Unable or unwilling to provide informed consent, cognitive impairment
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04253834). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search